06Jun
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...
By:
Morrison & Foerster LLP - Class Dismissed
Related
As governments around the world work to stem the coronavirus (COVID-19) pandemic, merger control aut...
Read More >
In a new paper, Alternative Venture Capital: The New Unicorn Investors, professor Anat Alon-Beck exp...
Read More >
The calculation of holiday pay has been the subject of a number of cases over recent weeks. There ar...
Read More >
With Independence Day nearly upon us (and with many offices on skeleton crews this week), I thought ...
Read More >
The UK’s competition authority has stepped up its enforcement of procedural breaches of merger cont...
Read More >
The Illinois Department of Human Rights (IHDR) has answered the call for clarity and provided guidan...
Read More >